Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001037389 | SCV001200800 | likely benign | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002479241 | SCV002781177 | uncertain significance | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71; Bardet-Biedl syndrome 20 | 2022-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031029 | SCV004886216 | uncertain significance | Inborn genetic diseases | 2024-02-27 | criteria provided, single submitter | clinical testing | The c.235A>G (p.T79A) alteration is located in exon 3 (coding exon 3) of the IFT172 gene. This alteration results from a A to G substitution at nucleotide position 235, causing the threonine (T) at amino acid position 79 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004553568 | SCV004751054 | likely benign | IFT172-related disorder | 2020-03-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |